story of the week
Inhaled Budesonide in the Treatment of Early COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Inhaled Budesonide in the Treatment of Early COVID-19 (STOIC): A Phase 2, Open-Label, Randomised Controlled Trial
Lancet Respir Med 2021 Apr 09;[EPub Ahead of Print], S Ramakrishnan, DV Nicolau, B Langford, M Mahdi, H Jeffers, C Mwasuku, K Krassowska, R Fox, I Binnian, V Glover, S Bright, C Butler, JL Cane, A Halner, PC Matthews, LE Donnelly, JL Simpson, JR Baker, NT Fadai, S Peterson, T Bengtsson, PJ Barnes, REK Russell, M BafadhelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.